Press Release – Exsurgo A recent UK study has confirmed the exciting potential of a breakthrough treatment for chronic pain management developed by New Zealand neuroscience company, Exsurgo. Chronic pain (defined as pain that persists for longer than three months) affects …
A recent UK study has confirmed the exciting potential of a breakthrough treatment for chronic pain management developed by New Zealand neuroscience company, Exsurgo.
Chronic pain (defined as pain that persists for longer than three months) affects up to 1 in 5 people around the world and is a massive burden on healthcare systems and economies. A 2018 report commissioned by the Australian and New Zealand College of Anaesthetists (ANZCA) estimated the total annual cost to New Zealand of chronic pain at $13-14.9 billion – greater than those for diabetes, dementia and smoking.[1]
A recent UK study has confirmed the exciting potential of a breakthrough treatment for chronic pain management developed by New Zealand neuroscience company, Exsurgo. Chronic pain (defined as pain that persists for longer than three months) affects .